Wealth Enhancement Advisory Services’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
NAM
TAL
FTCM
Wealth Enhancement Advisory Services's AVNS Position: Q2 2026 in Review
Wealth Enhancement Advisory Services reduced its Avanos Medical (AVNS) stake by 57% in Q2 2026, selling an estimated $332K and leaving 10,576 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #3327.
Wealth Enhancement Advisory Services first reported a position in AVNS in Q2 2025 and has held it in 5 quarters since. The position peaked at $345K in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.
- Wealth Enhancement Advisory Services held 10,576 shares of Avanos Medical worth $264K as of Q2 2026.
- Wealth Enhancement Advisory Services sold 14,176 Avanos Medical shares in Q2 2026, an estimated $332K.
- Avanos Medical made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3327 holding.
- Wealth Enhancement Advisory Services first reported a position in Avanos Medical in Q2 2025 and has held it in 5 quarters since.
- Wealth Enhancement Advisory Services's Avanos Medical position peaked at $345K in Q1 2026.
- 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.